Drugs Made In America Acquisition (DMIIR) Assets Average (2025)

Drugs Made In America Acquisition's (DMIIR) quarterly Assets Average came in at $503.0 million in Q4 2025, up 100.73% on a QoQ basis from $250.6 million in Q3 2025.

Drugs Made In America Acquisition (DMIIR) Assets Average (2025) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has 1 years of Assets Average data on file, last reported at $503.0 million in Q4 2025.

  • On a quarterly basis, Assets Average changed N/A year-over-year to $503.0 million in Q4 2025; TTM through Dec 2025 was $503.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $252.5 million, changed N/A from the prior year.
  • Assets Average for Q4 2025 stood at $503.0 million, up from $250.6 million in the prior quarter.
  • Over the last five years, Assets Average for DMIIR reached as high as $503.0 million in Q4 2025 and fell as low as $250.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 EQV Ventures Acquisition 480.75 Mn 480.75 Mn - 472.34 Mn
2 Agriculture & Natural Solutions Acquisition 393.29 Mn 393.29 Mn - 372.24 Mn
3 Berto Acquisition 314.56 Mn 314.35 Mn - 310.58 Mn
4 GP-Act III Acquisition 313.66 Mn 313.66 Mn - 307.93 Mn
5 Centurion Acquisition 311.65 Mn 311.65 Mn - 309.64 Mn
6 Republic Digital Acquisition 310.50 Mn 309.63 Mn - 310.49 Mn
7 Siddhi Acquisition Corp (Cayman Islands) 288.97 Mn 288.97 Mn - 287.89 Mn
8 K&F Growth Acquisition 283.42 Mn 283.42 Mn - 299.27 Mn
9 Bold Eagle Acquisition 275.29 Mn 275.29 Mn - 271.71 Mn
10 Drugs Made In America Acquisition - - - 502.98 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 502.98 Mn
Sep 30, 2025 250.57 Mn